|
|
||||||||
LIVER AND BILIARY TRACT
-mediated lysosomal permeabilization is FAN and caspase 8/Bid dependent
1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905; and 2Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260
Submitted 15 January 2004 ; accepted in final form 29 March 2004
TNF-
cytotoxic signaling involves lysosomal permeabilization with release of the lysosomal protease cathepsin B (ctsb) into the cytosol. However, the mechanisms mediating lysosomal breakdown remain unclear. Because caspase-8 and factor associated with neutral sphingomyelinase activation (FAN) have been implicated as proximal mediators of TNF-
-associated apoptosis, their role in lysosomal permeabilization was examined. Cellular distribution of ctsb-green fluorescent protein (ctsb-GFP) in a rat hepatoma cell line was imaged by confocal microscopy. ctsb-GFP fluorescence was punctate under basal conditions but became diffuse after treatment with TNF-
/actinomycin D. This cellular redistribution of ctsb-GFP was blocked by transfection with a vector expressing a dominant-negative Fas-associated protein with death domain (
FADD), cytokine response modifier A, or a pharmacological caspase-8 inhibitor, IETD-fmk. Consistent with the concept that caspase 8-mediated apoptosis is also Bid-dependent in hepatocytes, ctsb-GFP release from lysosomes was reduced in hepatocytes from Bid/ mice. Interestingly, transfection with a vector expressing a dominant-negative FAN (
FAN) also blocked ctsb-GFP release and caspase-8 activation. Paradigms that inhibited ctsb-GFP release from lysosomes also reduced apoptosis as assessed by morphology and biochemical criteria. In conclusion, these studies suggest FAN is upstream of caspase-8/Bid in a signaling cascade culminating in lysosomal permeabilization.
cathepsin B; dominant-negative Fas-associated protein with death domain; dominant-negative factor associated with neutral sphingomyelinase activation; green fluorescent protein
This article has been cited by other articles:
![]() |
M. E. Guicciardi, S. F. Bronk, N. W. Werneburg, and G. J. Gores cFLIPL prevents TRAIL-induced apoptosis of hepatocellular carcinoma cells by inhibiting the lysosomal pathway of apoptosis Am J Physiol Gastrointest Liver Physiol, May 1, 2007; 292(5): G1337 - G1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gyrd-Hansen, T. Farkas, N. Fehrenbacher, L. Bastholm, M. Hoyer-Hansen, F. Elling, D. Wallach, R. Flavell, G. Kroemer, J. Nylandsted, et al. Apoptosome-Independent Activation of the Lysosomal Cell Death Pathway by Caspase-9 Mol. Cell. Biol., November 1, 2006; 26(21): 7880 - 7891. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. E. Feldstein, N. W. Werneburg, Z. Li, S. F. Bronk, and G. J. Gores Bax inhibition protects against free fatty acid-induced lysosomal permeabilization Am J Physiol Gastrointest Liver Physiol, June 1, 2006; 290(6): G1339 - G1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Broker, F. A.E. Kruyt, and G. Giaccone Cell Death Independent of Caspases: A Review Clin. Cancer Res., May 1, 2005; 11(9): 3155 - 3162. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |